financetom
AZTA
financetom
/
Healthcare
/
AZTA
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Azenta, Inc.AZTA
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions.

This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics.

The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors.

It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes.

The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021.

Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Latest News >
Eshallgo Gets Equity Financing of up to $20 Million From CS Fund
Eshallgo Gets Equity Financing of up to $20 Million From CS Fund
Dec 20, 2024
10:46 AM EST, 12/20/2024 (MT Newswires) -- Eshallgo ( EHGO ) is set to receive up to $20 million in equity investment in tranches from CS Asia Opportunities Master Fund, the companies said Friday. Under their securities purchase agreement, CS Fund will buy up to about 4.2 million shares of Eshallgo ( EHGO ) at $4.80 per share in tranches,...
Playtika, International Game Technology Partner to Bring Slots to Social Casino Games
Playtika, International Game Technology Partner to Bring Slots to Social Casino Games
Dec 20, 2024
10:50 AM EST, 12/20/2024 (MT Newswires) -- Playtika Holding ( PLTK ) said Friday it formed a partnership to bring some of International Game Technology's ( IGT ) slot themes to Playtika's ( PLTK ) social casino games. IGT slot titles will appear in Playtika's ( PLTK ) Slotomania, Caesars Slots, and House of Fun beginning this month and heading...
--Netflix, FIFA Sign Broadcast Deal for Women's World Cup for 2027, 2031
--Netflix, FIFA Sign Broadcast Deal for Women's World Cup for 2027, 2031
Dec 20, 2024
10:50 AM EST, 12/20/2024 (MT Newswires) -- Price: 904.23, Change: +2.19, Percent Change: +0.24 ...
Vanda Pharmaceuticals' Prospective Treatment for Blood Cancer Receives US FDA's Orphan Drug Designation
Vanda Pharmaceuticals' Prospective Treatment for Blood Cancer Receives US FDA's Orphan Drug Designation
Dec 20, 2024
10:47 AM EST, 12/20/2024 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) said Friday morning that the US Food and Drug Administration has designated the company's VGT-1849A product candidate as an orphan drug to treat polycythemia vera, a rare form of hematologic malignancy affecting about one in every 2,000 people in the country. The FDA uses orphan drug designation to...
Copyright 2023-2025 - www.financetom.com All Rights Reserved